網頁Prior to founding Stemline, Dr. Bergstein was Medical Director of Access Oncology, Inc., a clinical stage oncology-focused biotechnology company where he was a key member of a small team responsible for the acquisition and development of the company’s 網頁2024年12月21日 · NEWTON, Mass. and FLORENCE, Italy, Dec. 21, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group, ("Menarini"), a privately-held, leading international pharmaceutical company, today announced their …
Anna Flores - Executive Assistant to Chief Medical Officer at Stemline Therapeutics …
網頁2024年5月5日 · Italian pharmaceutical and diagnostics company Menarini Group has signed a definitive agreement to acquire US-based Stemline Therapeutics for up to $677m. … 網頁2024年1月30日 · Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million. Acquisition of Stemline establishes Menarini’s presence in the … medieval strategy games free online
Stemline Therapeutics acquired by Menarini Group - SeekingAlpha
網頁The acquisition gives the Florence-based company access to Stemline’s Elzonris, a novel targeted therapy directed to the interleukin-3 receptor-α (CD123). Stemline has launched Elzonris for treating blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children two years or older following approval in the US in December 2024. 網頁THIS NOTE IS SUBJECT TO THE TERMS AND PROVISIONS OF THE NOTE PURCHASE AGREEMENT AMONG STEMLINE THERAPEUTICS, INC. AND THE OTHER PARTIES THERETO DATED AS OF MARCH 16, 2010, AS AMENDED FROM TIME TO TIME, AND IS ENTITLED TO THE BENEFITS THEREOF. 網頁2024年6月11日 · FLORENZ, Italien– (BUSINESS WIRE)–Die Menarini Group, ein in Privatbesitz befindliches italienisches Pharma- und Diagnostikunternehmen, meldete heute den erfolgreichen Abschluss der Übernahme von Stemline Therapeutics Inc., einem kommerziell tätigen biopharmazeutischen Unternehmen mit Schwerpunkt auf der … naga lightweight